AZO is not a good buy right now for a beginner long-term investor who wants to act immediately. The stock remains a high-quality business, but the current setup is mixed: technicals are bearish, short-term price patterns point lower, and recent financials show revenue growth but weaker profitability. Analyst sentiment is still constructive overall, yet the latest target changes are slightly mixed and the stock is already trading near the lower end of the analyst target range rather than clearly undervalued. With no strong proprietary buy signal and no fresh catalyst in the news, this is a hold rather than an immediate buy.
Current price is 3558, just above the pivot at 3584.765 and below resistance at 3687.837, indicating limited upside momentum near term. The MACD histogram is negative and expanding, which confirms weakening trend momentum. RSI_6 at 49.862 is neutral, so there is no oversold buying signal. The moving average structure is bearish (SMA_200 > SMA_20 > SMA_5), which is not supportive of an immediate entry. Support sits at 3481.694 and then 3418.017, while resistance is 3687.837 and 3751.514. The stock trend model also projects weakness over the next week and month.

["Analysts remain mostly bullish overall, with multiple Buy/Outperform ratings still in place.", "TD Cowen and Oppenheimer both raised targets and highlighted improving DIFM market share and better commercial sales productivity.", "Argus upgraded the stock to Buy and sees an inflection point in profit growth starting in Q3.", "Revenue in the latest quarter grew 8.15% YoY, showing the business is still expanding."]
["No news in the recent week, so there is no fresh event-driven catalyst.", "Latest quarter net income declined 3.91% YoY and EPS fell 2.33% YoY.", "Gross margin declined 2.54% YoY, showing profitability pressure.", "Technicals are bearish with negative MACD expansion and a weak moving average structure.", "Historical stock trend data suggests downside over the next week and month.", "Hedge funds and insiders are neutral with no meaningful recent accumulation.", "Congress trading was balanced, with one buy and one sell, offering no strong directional signal."]
In 2026/Q2, AutoZone delivered revenue of 4,274,098,000, up 8.15% year over year, which is a solid growth trend. However, net income fell 3.91% YoY to 468,860,000, EPS declined 2.33% YoY to 27.63, and gross margin slipped to 52.49, down 2.54%. This shows sales growth is intact, but margins and earnings momentum softened in the latest quarter season (Q2 2026).
Wall Street remains generally constructive. Recent actions include TD Cowen lowering its target to $4,250 but keeping Buy, Oppenheimer raising to $4,300 with Outperform, and Argus upgrading to Buy with a $4,325 target. Several firms trimmed targets after Q2 due to softer comps and weather-related pressure, including Mizuho, BMO, Evercore, Morgan Stanley, Roth, and Truist, but most maintained positive ratings. Pros: strong long-term market share gains, improving commercial/DIFM execution, and expectations for profit growth inflection. Cons: near-term comp sales softness, margin pressure, and less visibility into stabilization of revenue and margins.